Transcripts - Operator Good day, and welcome to the Travere Therapeutics Corporate Update Call. Today’s conference call is being recorded. At this time, I would like to … Continue Reading
Read nowInsights - In a prior note, we shared how weight-loss drugs might impact obesity related markets. The hype craze has pushed additional data that is now being blown … Continue Reading
Read nowTranscripts - Operator Welcome to the Delcath Systems Business Update Conference Call. [Operator Instructions] Please note this event is being recorded. I would now like to turn … Continue Reading
Read nowInsights - The wild weekend was followed by an eventful Monday, especially for the biotech world. The SVB fiasco saw a solution that was a relief for … Continue Reading
Read nowInsights - Silicon Valley Bank’s collapse has caused a ripple amongst the biotech world as the bank did business with about half of American tech and biotech … Continue Reading
PremiumInsights - Day One’s Drug Ready for NDADay One Pharma (DAWN) is developing tovorafenib (DAY101), an oral pan-RAF inhibitor for pediatric low-grade gliomas (pLGG). Despite being the … Continue Reading
PremiumInsights - Below are a few names to watch, each divided into a different segment. Value: Atyr Pharma (LIFE)Atyr Pharma is currently enrolling for a pivotal Phase … Continue Reading
Premium
